Çukurova Bölgesinde akut lenfoblastik lösemili çocuklarda vasküler endotelyal büyüme faktörü (VEGF-C) ve temel fibroblast büyüme faktörü (bFGF) plazma ekspresyonu ve metilasyon seviyeleri

Amaç: Bu çalışmanın amacı akut lenfoblastik lösemili (ALL) çocuklarda vasküler endotel büyüme faktörü-C (VEGF-C) ve temel fibroblast büyüme faktörünün (bFGF) ekspresyon ve metilasyon düzeylerini belirlemekti.Gereç ve Yöntem: Gerçek zamanlı kantitatif PCR ile yeni tanı almış olan 26 hasta ve 26 sağlıklı kontrolün periferik kan örneklerinde VEGF-C ve bFGF genlerinin mRNA ekspresyon profilleri ve metilasyon seviyelerini tespit ettik.Bulgular: bFGF ekspresyon seviyesi ALL hastalarında kontrollere kıyasla anlamlı derecede artmıştı (4.23 kat). Ayrıca, VEGF-C ALL hastalarında kontrollere kıyasla anlamlı derecede azalmıştı (3.41 kat). VEGF-C (%6.88) ve bFGF (%16.64) genlerinin promotor bölgelerinin metilasyon oranı ALL hastalarında sağlıklı kontroller göre daha yüksekti.Sonuç: Hastaların yıllar süren takibi sonucunda VEGF-C ve bFGF'de farklı zaman aralıklarında uzun süreli değişiklikler hastalık riski ile daha güçlü ilişkiler gösterebilir. Hem VEGF-C hem de bFGF ve ALL risk faktörleri ile güçlü bağlantılar kurmak için daha ileri çalışmalara ihtiyaç vardır.

Plasma expression and methylation levels of vascular endothelial growth factor (VEGF-C) and basic fibroblast growth factor (bFGF) in children with acute lymphoblastic leukemia in Çukurova Region, Turkey

Purpose: The aim of this study was to determine the expression and methylation levels of vascular endothelial growth factor-C (VEGF-C) and basic fibroblast growth factor (bFGF) in children with acute lymphoblastic leukemia (ALL).Materials and Methods: We detected mRNA expression profiles and methylation levels of VEGF-C and bFGF genes in the peripheral blood samples of 26 patients with newly diagnosed ALL and 26 healthy controls by real-time quantitative PCR. Results: The expression level of bFGF was significantly increased (4.23-fold) in ALL patients as compared with controls. Moreover, VEGF-C were significantly decreased (3.41-fold) in ALL patients as compared with controls. The methylation of the promoter region of VEGF-C (6.88%) and bFGF (16.64%) genes was higher in ALL patients than in healthy controls. Conclusion: Long-term changes in VEGF-C and bFGF at different time intervals as a result of years of follow-up of patients may show stronger associations with disease risk. Further studies are required to establish strong links with both VEGF-C and bFGF, and ALL risk factors. 

___

  • 1. Moehler TM, Ho AD, Goldschmidt H, Barlogie B. Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol. 2003;45:227-44.
  • 2. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011-27.
  • 3. Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood. 1999;94:3717-21.
  • 4. Salven P, Orpana A, Teerenhovi L, Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in nonHodgkin lymphoma: a single-institution study of 200 patients. Blood. 2000;96:3712-18.
  • 5. Ribatti D, Scavelli C, Roccaro AM, Crivellato E, Nico B, Vacca A. Hematopoietic cancer and angiogenesis. Stem Cells Dev. 2004;13:484-95.
  • 6. Podar K, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood. 2005;105:1383–95.
  • 7. Faderl S, Do KA, Johnson MM, Keating M, O'brien S, Jilani I et al. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia. Blood. 2005;106:4303-07.
  • 8. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192-8.
  • 9. Dias S, Choy M, Alitalo K, Rafii S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4(VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood. 2002;99:2179-84.
  • 10. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997;150:815- 21.
  • 11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620- 5.
  • 12. Rothe G. Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia. 1996;10.5:877-95.
  • 13. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276:1423-25.
  • 14. Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7:199-205.
  • 15. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA. 1998;95:14389–94.
  • 16. Fielder W, Graeven U, Ergun S, S Verago, N Kilic, M Stockschläder et al. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia. 1997;11:1234-37.
  • 17. De Jonge HJM, Valk PJM, Veeger NJGM, ter Elst A, den Boer ML, Cloos J et al. High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia. Blood. 2010;116:1747-54.
  • 18. Aliparasti MR, Almasi S, Sanaat Z, Movasaghpoor A, Khalili-Dizaji R, Sadeghi-Bazargani H. Gene expression of VEGF-A and VEGF-C in peripheral blood mononuclear cells of Iranian patients with acute myeloid leukemia. Turk J Hematol. 2013;30:137-43.
  • 19. Nowicki M, Ostalska‐Nowicka D, Kaczmarek E, Miskowiak B, Witt M. Vascular endothelial growth factor C a potent risk factor in childhood acute lymphoblastic leukemia: an immunocytochemical approach. Histopathology. 2006;49:170-7.
  • 20. Stachel D, Albert M, Meilbeck R, Paulides M, Schmid I. Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia. Oncol Rep. 2007;17:147-52.
  • 21. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000;95:309-13.
  • 22. Cao R, Ji H, Feng N, Zhang Y, Yang X, Andersson P, et al. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis. Proc Natl Acad Sci USA. 2012;109:15894- 9.
  • 23. Lyu CJ, Rha SY, Won SC. Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia. Yonsei Med J. 2007;48:171-5.
  • 24. Yetgin S, Yenicesu I, Cetin M, Tuncer M. Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2001;42:83-8.
  • 25. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol. 2009;27:361-8.
  • 26. Rahmani M, Talebi M, Hagh MF, Feizi AAH, Solali S. Aberrant DNA methylation of key genes and acute lymphoblastic leukemia. Biomed Pharmacother. 2018;97:1493-1500.
  • 27. Nordlund J, Syvänen AC. Epigenetics in pediatric acute lymphoblastic leukemia. Semin Cancer Biol. 2018;51:129-38.
  • 28. Dai W, Zeller C, Masrour N, Siddiqui N, Paul J, Brown R. Promoter CPG island methylation of genes in key cancer pathways associates with clinical outcome in high grade serous ovarian cancer. Clin Cancer Res. 2013;19:5788-97.
  • 29. Matsumura S, Oue N, Mitani Y, Kitadai Y, Yasui W. DNA demethylation of vascular endothelial growth factor‐C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer. Int J Cancer. 2007;120:1689-95.
  • 30. Jung GA, Shin BS, Jang YS, Sohn JB, Woo SR, Kim JE et al. Methylation of eukaryotic elongation factor 2 induced by basic fibroblast growth factor via mitogenactivated protein kinase. Exp Mol Med. 2011;43:550- 60.
  • 31. Van Vliet J, Oates NA, Whitelaw, E. Epigenetic mechanisms in the context of complex diseases. Cell Mol Life Sci. 2007;64:1531-38.
  • 32. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 2002;21:5400-13.
  • 33. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer. 2005;5:223–31.
Cukurova Medical Journal-Cover
  • ISSN: 2602-3032
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1976
  • Yayıncı: Çukurova Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

Çukurova Bölgesinde akut lenfoblastik lösemili çocuklarda vasküler endotelyal büyüme faktörü (VEGF-C) ve temel fibroblast büyüme faktörü (bFGF) plazma ekspresyonu ve metilasyon seviyeleri

Nihal İNANDIKLIOGLU, Osman DEMİRHAN, İbrahim BAYRAM, Atila TANYELİ

Asemptomatik kreatin kinaz (CK) yüksekliği: Hiper-CK-emi

Oğuz Abdullah UYAROĞLU

Laparoskopik endometrioma kistektomi cerrahilerinde elektrokoagülasyon veya sütür tekniği ile sağlanan hemostazın rekürrens ve gebelik sağlama oranına etkisi

Şükrü YILDIZ, Cihan KAYA, İsmail ALAY, Murat EKİN, Levent YAŞAR

Çocuk femur cisim kırıklarında titanyum elastik çivileme cerrahisinin uzun dönemde femur gelişimine etkisi

Gökhan Bülent SEVER

Cleveland Adölesan Uykululuk Anketi’nin Türkçe’ye uyarlanması: Lise öğrencileri için geçerlik-güvenirlik çalışması

Songül ÇAĞLAR, Makbule TOKUR KESGİN

Bir eğitim hastanesinde farmakovijilans merkezine yönlendirilen yatan hastalardaki advers ilaç reaksiyonlarının analizi

Zakir KHAN, Emine ÖZ EKEMEN, Olcay KIROĞLU, Yusuf KARATAŞ

Şanlıurfa’nın Halfeti ilçesindeki akut gastroenteritli çocuklarda rotavirüs ve adenovirüs sıklığı

Adnan BARUTÇU, Saliha BARUTÇU

Corona Virüsü Hastalığı 2019 Pandemi tehdidi altında vatandaşların güvenli bir şekilde geri gönderilmesinin sağlanması

Saurabh SHRİVASTAVA, Prateek SHRİVASTAVA

Juvenil idiopatik artritli Türk çocukların büyüme parametreleri

Sibel BALCI, Mehmet ÇALKAN, Semine ÖZDEMİR DİLEK, Dilek DOĞRUEL, Derya ALTİNTAS, Rabia Miray KİSLA EKİNCİ

Posterior mediastinal kistik schwannomun nadir prezentasyonu

Aslı TANRIVERMİŞ SAYIT, M ELMALİ